Gene: PRSS23
Official Full Name: serine protease 23provided by HGNC
Gene Summary: This gene encodes a conserved member of the trypsin family of serine proteases. Mouse studies found a decrease of mRNA levels of this gene after ovulation was induced. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06322 | PRSS23 Knockout cell line (HeLa) | Human | PRSS23 | 1:3~1:6 | Negative | Online Inquiry |
KO06323 | PRSS23 Knockout cell line (HCT 116) | Human | PRSS23 | 1:2~1:4 | Negative | Online Inquiry |
KO06324 | PRSS23 Knockout cell line (HEK293) | Human | PRSS23 | 1:3~1:6 | Negative | Online Inquiry |
KO06325 | PRSS23 Knockout cell line (A549) | Human | PRSS23 | 1:3~1:4 | Negative | Online Inquiry |
PRSS23 Gene Knockout Cell Lines are a state-of-the-art tool designed for advanced biological research focused on understanding the functional role of the PRSS23 gene in various cellular processes and disease mechanisms. These engineered cell lines are generated through targeted gene editing techniques, most notably CRISPR-Cas9, resulting in the complete knockout of the PRSS23 gene, which encodes for a serine protease implicated in several physiological and pathological conditions.
The key function of PRSS23 Gene Knockout Cell Lines lies in their ability to facilitate the investigation of gene function by providing researchers with a cellular model that lacks the specific gene product, thereby enabling the study of downstream effects on cellular pathways. By comparing the knockout lines with wild-type counterparts, scientists can elucidate the biological role of PRSS23 in processes such as cell signaling, proliferation, and apoptosis, making these cell lines invaluable for both fundamental biology and translational research.
Scientifically, PRSS23 has gained attention due to its potential involvement in tumor progression and immune responses, which then reflects its significant applications in the biopharmaceutical sector, including drug discovery and target validation. Researchers can utilize these cell lines to screen for therapeutic compounds or to explore gene-editing strategies in a controlled environment, thus accelerating the development of novel treatment modalities.
A considerable advantage of our PRSS23 Gene Knockout Cell Lines is the precision and efficiency achieved through our proprietary gene editing protocols, which minimize off-target effects and ensure a high degree of specificity. Unlike alternative models, which may not completely eliminate the gene function or can introduce confounding factors, our knockout lines provide a reliable and reproducibly validated resource for elucidative studies.
Investing in PRSS23 Gene Knockout Cell Lines translates to significant value for researchers and clinicians who aim to unlock the intricacies of gene function and its implications in health and disease. By harnessing our products, users tap into a robust experimental foundation that advances their scientific inquiries, leading to groundbreaking insights.
At [Your Company Name], we pride ourselves on our commitment to excellence in developing high-quality biological products tailored for cutting-edge research. With years of expertise in genomic technologies and cell line development, we strive to empower our customers with the tools necessary for making impactful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.